Biologit, an Irish tech company focused on drug safety, has raised €1 million from investors.
Gerard Ryan, founder of Longboat Clinical, a clinical trials platform, David Shanahan, a life sciences veteran, and Enterprise Ireland have all lined up to back the Trinity College spin-out. Founded by Nicole Baker and Bruno Ohana in 2019, the company has developed an artificial intelligence-powered platform that monitors scientific and medical literature to provide up-to-date information for clinical safety and pharmacovigilance.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: